Carboplatin/pembrolizumab/pemetrexed

Colitis: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Zubiri L, et al. Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy. Oncologist 25: e398-e404, No. 3, Mar 2020. Available from: URL: http://doi.org/10.1634/theoncologist.2018-0883

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Carboplatin/pembrolizumab/pemetrexed. Reactions Weekly 1806, 76 (2020). https://doi.org/10.1007/s40278-020-79094-2

    Download citation